when the animal host is filled with bacteria. ( iii) The distribution of the germs in the internal organs of the mouse shortly after infection was dependent on the route of infection rather than on the serotype used. (iv) The main difference among the Listeria serotypes tested was their ability to multiply within the host and to induce a granulomatous inflammation. The results indicate that mouse pathogenicity and virulence of Listeria spp. cannot be defined only by the capacity of the bacteria to infect or kill conventional mice. Such a definition should include an analysis of the immune system of the host, a kinetic study of experimental infection, and a histomorphological evaluation of the lesions induced. Infections of humans and animals with bacteria of the genus Listeria are common throughout the world. Human infection, resulting in severe and sometimes fatal disease, is predominantly caused by Listeria monocytogenes serotypes 1/2b and 4b (17) . Other serotypes of this species have been described, including serotype 6, now called Listeria innocua (18) . The experimental infection of mice with L. monocytogenes serotype 4b is almost routine in several laboratories, since these bacteria provide an excellent model for studying the mechanism of cell-mediated immunity to infection. Resistance to L. monocytogenes is thought to be mediated by macrophages that are activated by specifically sensitized T-lymphocytes (2, 10, 13, 23) . The only successful experimental infection with L. innocua has been achieved by Patocka et al. (14) with an intracerebral infection of suckling mice. Since no detailed information about the cellular kinetics and the histological changes during infection with L. innocua is available, it seemed reasonable to perform the following experiments. A model for infection with different Listeria serotypes including information about the response of the host to the different bacterial challenges would, furthermore, provide information about how to define the pathogenicity and immunogenic capacity of the various serotypes of the species. MATERIALS Corp., Dreieich, Federal Republic of Germany) for 2 h at 37°C. After incubation, the bacteria were pelleted, washed three times in phosphate-buffered saline containing 25 mmol of deoxyuridine (Sigma Chemical Co., Munich, Federal Republic of Germany), and diluted in phosphate-buffered saline plus deoxyuridine. Autopsy was performed 2 h after infection of mice. Peritoneal exudate cells were harvested after peritoneal lavage with 1.0 ml of RPMI 1640 medium (Mediapharm, Munich, Federal Republic of Germany) containing 2.0 USP-E of heparin per ml. The liver, spleen, kidneys, pancreas, and lungs were also recovered, and the gamma radiation of the organs was determined. The results were expressed as the percentage of radioactivity of the injected dose.
Cell transfer. Cell transfer was performed with purified spleen cells. After aseptic removal of the spleen, it was homogenized (glass homogenizer) in 2.0 ml of RPMI 1640 medium containing 1.0 USP-E of heparinper ml. The cells were filtered through gauze and purified over a Ficoll-Hypaque gradient (Pharmacia, Uppsala, Sweden). The recovery was 85 to 90% viable cells. Viability was assured by dye exclusion tests. Distribution of Listeria sp. in internal organs. The distribution of radiolabeled bacteria in spleen, kidneys, lungs, or pancreas showed that none of the organs incorporated more than 5% of the total activity. Significantly higher values could be recovered from the liver and from peritoneal exudate cells. Table 2 gives the percentage of radioactivity recovered from both materials after i.p. or i.v. infection. As can be seen, the liver is the main clearing organ after i.v. infection, whereas peritoneal exudate cells serve as the initial barrier after i.p. infection. No significant differences could be observed with respect to the initial clearing of bacteria after infection with any of the serotypes of L. monocytogenes and L. innocua.
Course of infection in spleen. Figure 1 shows the course of infection with the different Listeria serotypes in the spleen, expressed as numbers of CFU recovered from the spleen. It can be seen that the injection of 3. 5 intense inflammation corresponding to that previously described by others (9, 11, 13) and by our group (4, 6) . Three days after infection, numerous pyogenic foci with or without necrosis were present in the livers of experimental animals (Fig. 3A) . Nine days after infection, lesions frequently showed a distinct granulomatous character (Fig. 4A) . In contrast, mice infected with L. innocua serotype 6b showed a weak inflammatory response. Three days after infection, single pyogenic foci were detectable in the liver (Fig. 3B) , whereas after nine days, no lesions at all could be found in this organ (Fig.  4B) inflammatory processes in the two experimental animal groups differed considerably. Whereas serotype 4b organisms caused extensive lesions in the spleen (Fig. 5) , serotype 6b organisms induced only a minimal inflammatory reaction which rapidly disappeared (Fig. 5) .
Secondary infection. The following experimental schedules were designed to test whether a primary infection with the nonvirulent L. innoclia serotype 6b could induce protection against a lethal challenge with the virulent L. monocytogenes serotype 4b. Ten days after primary infection with 2.5 x 109 L. innocua cells, mice were challenged i.p. with twice the LD50 of viable L. monocytogenes serotype 4b. The course of the secondary infection is depicted in Fig. 6 (iv) The distinguishing difference between the strains tested seems to be the capacity to multiply in the host and to induce a chronic granulomatous inflammation as demonstrated for L. monocytogenes serotype 4b. Experimental infection with L. innocua serotype 6, using the method of intracerebral challenge of corticosteroid-treated suckling mice, has been described previously (14) . The results obtained have led to a discussion about how to define Listeria pathogenicity and virulence. Weiss and Seeliger (20) as well as Khan et al. (8) define virulence with respect to the ability of the bacteria to kill conventional mice or to be recovered from the organs of symptomless animals after certain intervals postinfection. Patocka et al. (14) stress the importance of the host for the difinition of bacterial pathogenicity. They define L. innocua as pathogenic (infective) for suckling mice upon intracerebral injection. Audurier et al. (1) , also working with L. innocua, emphasize the importance of enumeration of bacteria in the spleen and the use of different routes for infection. In accordance with these findings, the results of our experiments suggest that the definition of Listeria pathogenicity and virulence cannot be made only by the ability to kill or infect conventional mice. Since resistance and susceptibility of different mouse strains against Listeria are controlled by a single gene, Lr (19) , statements on Listeria virulence should be made with regard to the mouse strain being tested. Furthermore, the age of the animal host is important for resistance against infection (3, 22) , and this information should also be included. Our experiments indicate that the main feature of a pathogenic Listeria sp. is its ability to multiply in the susceptible host. This results in a granulomatous type of inflammation, mainly characterized by an infiltration with monocytes and macrophages (6, 9, 11, 13) . Consequently, the definition of Listeria pathogenicity and virulence should include a kinetic study of an experimental infection and a histomorphological evaluation.
The induction of protective immunity to a lethal challenge with L. monocytogenes serotype 4b by a primary infection with any serotype of L. monocytogenes and L. innocua tested suggests a common immunogenic principle for all listeriae. It could be shown by the passive transfer of spleen cells that the mechanism of protective immunity is basically identical to the mode of action first described by Miki and Mackaness (12) . Protective immunity, however, is rather short lived after primary infection with L. innocua, a finding that has been described by Kearns and Hinrichs (7) for infection with L. monocytogenes serotype 1/2b. The dose dependency of protective immunity after primary infection with L. innocua furthermore suggests that immunity can be acquired only when the animal host contains great numbers of microorganisms. This is made possible either by the injection of large doses of viable L. innocua or by multiplication of initially smaller numbers of L. monocytogenes serotype 4b in the host.
